PEGINTRON for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where PEGINTRON was used for Neoplasm.
Most Reported Side Effects for PEGINTRON
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 132 | 14.5% | 5 | 49 |
| Fatigue | 130 | 14.3% | 1 | 22 |
| Product quality issue | 118 | 13.0% | 1 | 3 |
| Headache | 96 | 10.6% | 3 | 17 |
| Pyrexia | 96 | 10.6% | 3 | 20 |
| Nausea | 93 | 10.2% | 1 | 17 |
| Drug dose omission | 85 | 9.4% | 0 | 4 |
| No adverse event | 77 | 8.5% | 0 | 0 |
| Influenza like illness | 75 | 8.3% | 0 | 6 |
| White blood cell count decreased | 74 | 8.2% | 2 | 14 |
| Decreased appetite | 73 | 8.0% | 2 | 20 |
| Haemoglobin decreased | 70 | 7.7% | 4 | 18 |
| Rash | 68 | 7.5% | 0 | 12 |
| Vomiting | 68 | 7.5% | 0 | 20 |
| Malaise | 63 | 6.9% | 3 | 17 |
Other Indications for PEGINTRON
Hepatitis c (498)
Chronic hepatitis c (249)
Hepatic cirrhosis (9)
Hepatitis c virus test positive (8)
Product used for unknown indication (5)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)